AstraZeneca PLC (AZN)

Growth

Revenue 5Y-
Revenue 3Y-
EPS 5Y-
EPS 3Y-
Dividend 5Y-
Dividend 3Y-

Capital Efficiency

ROIC-
ROE-
ROA-
ROTA-

Capital Structure

Market Cap202.19B
EV202.19B
Cash-
Current Ratio-
Debt/Equity-
Net Debt/EBITDA-
Show More

Segments & KPIs

Select a metric from the list below to chart it

Dec '12
Dec '14
Dec '16
Dec '18
Dec '20
TTM
Segments & KPIs
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
TTM
Oncology Revenue
Oncology Revenue % Chg.
BioPharmaceuticals: CVRM Revenue
BioPharmaceuticals: CVRM Revenue % Chg.
BioPharmaceuticals: R&I Revenue
BioPharmaceuticals: R&I Revenue % Chg.
BioPharmaceuticals V&I Revenue
Rare Disease Revenue
Rare Disease Revenue % Chg.
Other Medicines Revenue
Other Medicines Revenue % Chg.
COVID-19 Revenue
COVID-19 Revenue % Chg.
Collaboration Revenue
UK Revenue
UK Revenue % Chg.
Rest of Europe Revenue
Rest of Europe Revenue % Chg.
The Americas Revenue
The Americas Revenue % Chg.
Asia, Africa & Australasia Revenue
Asia, Africa & Australasia Revenue % Chg.
UK Operating Profit
UK Operating Profit % Chg.
Rest of Europe Operating Profit
Rest of Europe Operating Profit % Chg.
The Americas Operating Profit
The Americas Operating Profit % Chg.
Asia, Africa & Australasia Operating Profit
Asia, Africa & Australasia Operating Profit % Chg.
UK Assets Acquired
UK Assets Acquired % Chg.
Rest of Europe Assets Acquired
Rest of Europe Assets Acquired % Chg.
The Americas Assets Acquired
The Americas Assets Acquired % Chg.
Asia, Africa & Australasia Assets Acquired
Asia, Africa & Australasia Assets Acquired % Chg.